Apollo Hospitals Enterprise is currently trading at Rs. 6704.95, up by 8.80 points or 0.13% from its previous closing of Rs. 6696.15 on the BSE.
The scrip opened at Rs. 6715.55 and has touched a high and low of Rs. 6716.35 and Rs. 6640.00 respectively. So far 1495 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 7545.10 on 08-Nov-2024 and a 52 week low of Rs. 5690.80 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 6961.20 and Rs. 6640.00 respectively. The current market cap of the company is Rs. 96066.84 crore.
The promoters holding in the company stood at 29.33%, while Institutions and Non-Institutions held 65.48% and 5.19% respectively.
Apollo Hospitals Enterprise has signed a memorandum of understanding (MoU) with Mayapada Healthcare Group to provide its management expertise in Indonesia. Under this collaboration, the city-based healthcare provider will offer its operational services to Mayapada Healthcare's upcoming hospital in Batam, Indonesia.
Both organisations will leverage advanced technologies such as Tele-Radiology, E-ICU, and artificial intelligence programmes to improve patient care and accessibility. This agreement is expected to transform the healthcare landscape in Batam, Indonesia, by enhancing medical capabilities, clinical programs, and operational excellence. Following the partnership, Apollo Hospitals plans to deploy up to 1,000 specialists, including doctors, nurses, and technicians, to support Mayapada Healthcare's facilities.
Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: